newsfilter
← Latest News
PR Newswire·

NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China

NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven therapeutics, today...